DEVI CHETTIAR: Open Payments
NPI 1609198167 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 9 payments from 6 companies in 2025. Trend: 2023 $132 · 2024 $119 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| Kerecis Limited | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: TREMFYA, DUPIXENT, Odomzo, Kerecis SurgiClose, Sotyktu, OTEZLA.
Industry payments across MN — which companies pay providers there.
